AVTR (Avantor) Change In Payables And Accrued Expense : $110 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Avantor Change In Payables And Accrued Expense?

Avantor's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was $-1 Mil. It means Avantor's Accounts Payable & Accrued Expense declined by $1 Mil from Dec. 2024 to Mar. 2025 .

Avantor's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was $58 Mil. It means Avantor's Accounts Payable & Accrued Expense increased by $58 Mil from Dec. 2023 to Dec. 2024 .

Avantor Change In Payables And Accrued Expense Historical Data

The historical data trend for Avantor's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avantor Change In Payables And Accrued Expense Chart

Avantor Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

80.90

70.20

15.70

-139.30

58.00

Avantor Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-53.10	98.70	-20.20	32.60	-1.10

Avantor Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $110 Mil.

Avantor Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Avantor's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Avantor Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avantor Inc (NYSE:AVTR) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

AVG:Germany AVTR:Austria

Address

100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.avantorsciences.com

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Executives

Gregory L Summe	director	C/O GLEN CAPITAL PARTNERS LLC, 800 SOUTH STREET, SUITE 160, WALTHAM MA 02453
Joseph R Massaro	director	5725 DELPHI DRIVE, TROY MI 48098
Jonathan M Peacock	director	ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Lan Kang	director	100 MATSONFORD ROAD, RADNOR PA 19087
James Bramwell	officer: EVP, Strategic Partners	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Steven W Eck	officer: SVP & Chief Accounting Officer	C/O CSS INDUSTRIES, INC., 450 PLYMOUTH ROAD, SUITE 300, PLYMOUTH MEETING PA 19462
Christophe Couturier	officer: See Remarks	9 FOURTH AVENUE, C/O OVASCIENCE INC., CAMBRIDGE MA 02451
Benoit Gourdier	officer: EVP, Biopharma Production	100 MATSONFORD ROAD, RADNOR PA 19087
Frederic Vanderhaegen	officer: EVP, Europe	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Brittany Hankamer	officer: EVP, Chief HR Officer	100 MATSONFORD ROAD, RADNOR PA 19087
R. Brent Jones	officer: EVP, Chief Financial Officer	C/O PALL CORPORATION, 25 HARBOR PARK DRIVE, PORT WASHINGTON NY 11050
Claudius Sokenu	officer: EVP, Chief Legal & Compliance	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, BLUE BELL PA 19422
Randy Lee Stone	officer: EVP, Proprietary Products	974 CENTRE ROAD, CRP 730, WILMINGTON DE 19805
Gerard Brophy	officer: EVP, Biopharma Production	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Kitty Sahin	officer: EVP, Strategy&Corp Development	100 MATSONFORD ROAD, RADNOR PA 19087